NEW YORK (GenomeWeb) – Danaher announced today a definitive agreement to purchase General Electric's Biopharma business for a cash purchase price of $21.4 billion.
Factoring tax benefits from the structure of the deal, the net purchase price is about $20 billion, Danaher said.